Publication Topic

Frankenfeld CL, Leslie TF, Menon N. Racial disparities in colorectal cancer time-to-treatment in relation to residential segregation of the diagnostic hospital. Poster presentation to American Public Health Association, 2019.

Lowe K, Bylsma LC, Levin-Sparenberg ED, Sangaré L, Fryzek J, Alexander DD. Prevalence of KRAS, NRAS, and BRAF gene mutations in metastatic colorectal cancer patients: A systematic literature review and meta-analysis. Poster presentation at Gastrointestinal Cancers Symposium, San Francisco, California, January, 2019.

Lowe K, Bylsma LC, Dean R, Gillezeau C, Sangaré L, Alexander DD, Fryzek J. The incidence of infusion reactions associated with monoclonal antibody drugs targeting the epidermal growth factor receptor in metastatic colorectal cancer patients: A systematic literature review and meta-analysis. Poster presentation at Gastrointestinal Cancers Symposium, San Francisco, CA, January 2019.

Beebe-Dimmer JL, Ruterbusch JJ, Bylsma LC, Gillezeau C, Fryzek J, Schultz NM, Flanders SC, Barlev A, et al. 2018. Patterns of bicalutamide use in prostate cancer treatment: A U.S. real-world analysis using the SEER-Medicare database. Adv Ther 35(9):1438-1451; doi: 10.1007/s12325-018-0738-5. PMID: 29946798.

Sacks NC, Sharma A, Cyr PL, Bertiger G, Dahdal DN, Brogadir S. 2018. Real-world comparison of the effectiveness and safety of different bowel preparation agents. Clin Exp Gastroenterol 11(Aug 16):289–299; doi: 10.2147/CEG.S171861. PMID: 30555250.

Suh M, Wikoff D, Harvey S, Mittal L, Lipworth L, Goodman M, Goodmanson A, Ring C, Rohr A, Proctor D. Hexavalent chromium and stomach cancer: A systematic review and meta-analysis. Presented at Joint Annual Meeting of International Society of Exposure Science and International Society for Environmental Epidemiology (ISES-ISEE 2018), Ottawa, Canada, August 2018.

Proctor DM, Suh M, Chappell G, Borghoff SJ, Thompson CM, Wiench K, Finch L, Ellis-Hutchings R. 2018. An adverse outcome pathway (AOP) for forestomach tumors induced by non-genotoxic initiating events. Regul Toxicol Pharmacol 96(July):30-40; doi: 10.1016/j.yrtph.2018.04.016. PMID: 29684431.

Borghoff S, Wikoff D, Urban JD, Rager JE. A systematic approach to identify plausible mode-of-actions (MOA) for an increased incidence of lung tumors in mice with chronic exposure to 4-methylimidazole (4-MEI). Society of Toxicology 57th Annual Meeting, San Antonio, TX, March 2018.

Hathway J, Purdum AG, Lin VW, Cyr PL, Westin J, Jensen IS. A budget impact model of Axicabtagene Ciloleucil in a US population of patients with relapsed/refractory large B-cell lymphoma (RR-LBCL). European Blood and Marrow Transplantation Meeting, Lisbon Portugal, 2018.

Sacks NC, Sharma A, Cyr PL, Bertiger G, Dahdal DN, Brogadir S. 2018. Real-world evidence comparison of the efficacy and safety of different bowel preparation agents in a high-risk population. Gastroenterol 154(6) S632-S633; doi: 10.1016/S0016-5085(18)32266-2.

Sacks NC, Cyr PL, Louie AC, Liu Y, Chiarella MT, Sharma A, Chung KC. 2018. Burden of acute myeloid leukemia among older, newly diagnosed patients: Retrospective analysis of data from the 2010-2012 Medicare limited data set. Clin Ther 40(5):692–703.e2; doi: 10.1016/j.clinthera.2018.03.012. PMID: 29673891.

Schwartz KL, Simon MS, Bylsma LC, Ruterbusch JJ, Beebe-Dimmer JL, Schultz NM,  Flanders SC, Barlev A, et al. 2018. Clinical and economic burden associated with stage III to IV triple-negative breast cancer: A SEER-Medicare historical cohort study in elderly women in the United States. Cancer 124(10):2104-2114; doi: 10.1002/cncr.31299. PMID: 29505670.

Fryzek J, Reichert H, Summers N, Townes L, Deuson R, Alexander DD, Vanderpuye-Orgle J. 2018. Indirect treatment comparison of cabazitaxel for patients with metastatic castration-resistant prostate cancer who have been previously treated with a docetaxel-containing regimen. PLoS One 13(4):e0195790; doi: 10.1371/journal.pone.0195790. PMID: 29641566.

Burns AM, Benson SM, Best E, Hollins DM, Finley BL. An ecological epidemiology investigation of talc consumption in the US and trends in female cancer rates. Poster presentation at Society of Toxicology 57^th Annual Meeting, San Antonio, TX, 2018.

Frankenfeld CL, Hakes J, Leslie TF. All-cancer and cancer-specific mortality is associated with black race segregation in the United States: Mortality Disparities in American Communities data. American Association for Cancer Research: Poster presentation to The Science of Cancer Health Disparities, 2018.

Bylsma LC, Gillezeau C, Garawin T, Kelsh M, Fryzek J, Sangare L, Lowe KA. Prevalence of RAS and BRAF mutations in Metastatic Colorectal Cancer (mCRC) patients by tumor location. Presented at the Gastrointestinal Cancers Symposium, San Francisco, CA, January 2018.

Jensen IS, Wu E, Cyr PL, Gauden D. Cost-consequence of use of Fluciclovine (F 18) for the diagnosis and staging of recurring prostate cancer. ISPOR 16th Annual European Congress, Glasgow, Scotland, 2017.

Mullins M, Jiang X, Bylsma LC, Fryzek JP, Reichert H, Chen EC, Kummar S, Rosenthal A. 2017. Cold agglutinin disease burden: A longitudinal analysis of anemia, medications, transfusions, and healthcare utilization. Blood Adv 1(13):839-848; doi: 10.1182/bloodadvances.2017004390. PMID: 29296728.

Ruterbusch JJ, Bylsma LC, Fryzek J, Barlev A, et al. Bicalutamide treatment patterns in elderly prostate cancer patients: A historical cohort study using the Surveillance, Epidemiology and End Results Program (SEER)-Medicare database. Presented at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual International Meeting, Boston, MA, May 2017.

Finley BL, Scott PK, Burns AM, Marsh GM. Does PCB exposure cause non-Hodgkins lymphoma? A weight of evidence evaluation. Abstract 3240, Society of Toxicology 56^th Annual Meeting, Baltimore, MD, 2017.